Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
World Journal of Urology|May 10, 2014
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomySophie Hurel, Morgan Rouprêt, Thomas Seisen, et al.
World Journal of Urology|August 3, 2013
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinomaAlexandra Masson-Lecomte, Pierre Colin, Gregory Bozzini, et al.
The Prostate|July 13, 2017
Ductal adenocarcinoma of the prostate: Clinical and biological profilesArmelle Vinceneux, Franck Bruyère, Olivier Haillot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinomaMorgan Rouprêt, Géraldine Cancel-Tassin, Eva Comperat, et al.
European Urology Oncology|February 17, 2020
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression ProfileJean Hoffman-Censits, Woonyoung Choi, Sumanta Pal, et al.
Histopathology|August 28, 2015
Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinomaThu Tran, Carol L Jones, Sean R Williamson, et al.
European Urology|September 18, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladderMaximilian Burger, Willem Oosterlinck, Badrinath Konety, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 8, 2015
Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastomaStephanie N Kinney, John N Eble, Ondrej Hes, et al.
Hormones & Cancer|October 8, 2018
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study ResultsYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Pageof 19